We confirmed these results in the Eμ-TCL1 transgenic mouse model, which spontaneously develops CD19+CD5+ CLL-like disease and recapitulates immune dysfunction witnessed in patients (17, 18). The gene discussed is CD5; the disease is immune system disorder.